Document is current
Any future updates will be listed below
-
Authors
Soeung, Melinda https://orcid.org/0000-0002-6902-898X
Yan, Xinmiao
Zanca, Ciro
Qian, Jing
Karki, Menuka
Duan, Fei
Khan, Hania
Zhang, Li https://orcid.org/0000-0002-7750-6427
Peng, David H.
Williams, Mariah
He, Rong
Chen, Ziheng https://orcid.org/0000-0003-1918-106X
Perelli, Luigi https://orcid.org/0000-0001-7320-8193
Chen, Jianfeng
Tidwell, Rebecca S. https://orcid.org/0000-0003-3041-8582
Chauhan, Pankaj K. https://orcid.org/0000-0002-6054-5585
Le, Courtney N. https://orcid.org/0000-0003-4456-1478
Lam, Truong N. A.
Bhattacharya, Nirjar
Shah, Rutvi https://orcid.org/0000-0002-2382-9175
Ho, I-Lin
Gay, Jason P.
Carrillo, Caroline C.
Feng, Ningping
Le, Kang
Gao, Guang
Perry, Teresa L.
Mseeh, Faika
Jiang, Yongying
Xu, Quanyun A.
Zacharias, Niki Marie https://orcid.org/0000-0002-9364-6016
Sheth, Rahul A. https://orcid.org/0000-0001-9615-8985
Bathala, Tharakeswara K.
Rao, Priya https://orcid.org/0000-0001-5672-0961
Daw, Najat C. https://orcid.org/0000-0002-6941-8005
Tripathi, Durga N.
Walker, Cheryl L. https://orcid.org/0000-0002-4233-3247
Mohammad, Mohammad M.
Zhang, Jianhua https://orcid.org/0000-0001-5412-9860
Han, Guangchun https://orcid.org/0000-0001-9277-2507
Chu, Yanshuo
Wang, Ruiping
Dang, Minghao https://orcid.org/0000-0001-7287-2877
Dai, Enyu
Peng, Fuduan
Liu, Yunhe https://orcid.org/0000-0002-2120-952X
Jadhav, Akshaya https://orcid.org/0000-0002-1851-1306
Lang, Wenhua
Arrechedera, Claudio A. https://orcid.org/0009-0001-5358-480X
Clemente, Leticia Campos https://orcid.org/0000-0002-7917-8543
Parra, Edwin R. https://orcid.org/0000-0001-9068-1636
Lu, Hsinyi
Haymaker, Cara L. https://orcid.org/0000-0002-1317-9287
Wistuba, Ignacio I.
Futreal, Andrew https://orcid.org/0000-0001-8663-2671
Viale, Andrea
Soth, Michael J.
Jones, Philip https://orcid.org/0000-0001-6149-8293
Marszalek, Joseph R. https://orcid.org/0000-0003-2320-3209
Heffernan, Timothy https://orcid.org/0000-0002-3166-8922
Draetta, Giulio F. https://orcid.org/0000-0001-5225-9610
Tannir, Nizar M. https://orcid.org/0000-0001-5559-8060
Gao, Jianjun https://orcid.org/0000-0001-6138-4472
Wang, Linghua https://orcid.org/0000-0001-9380-0266
Genovese, Giannicola https://orcid.org/0000-0003-1392-9954
Msaouel, Pavlos https://orcid.org/0000-0001-6505-8308
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R37CA288448)
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 16 October 2025
First Online: 25 November 2025
Competing interests
: P. Msaouel has received honoraria for service on a Scientific Advisory Board for Mirati Therapeutics, Bristol Myers Squibb, and Exelixis; consulting for Axiom Healthcare Strategies; non-branded educational programs supported by DAVA Oncology, Exelixis and Pfizer; and research funding for clinical trials from Regeneron Pharmaceuticals, Summit Therapeutics, Merck, Takeda, Bristol Myers Squibb, Mirati Therapeutics, Gateway for Cancer Research, and UT MD Anderson Cancer Center. J. Gao serves as a consultant for AstraZeneca, Aveo Pharmaceuticals, CRISPR Therapeutics, Infinity Pharmaceuticals, Janssen, Jounce, Pfizer, Polaris, and Symphogen. N. M. Tannir reported receiving and personal fees (honoraria) from Calithera Biosciences during the conduct of the study; and grants (sponsored trial) from Calithera Biosciences, Bristol Myers Squibb (BMS), Nektar Therapeutics, Arrowhead Pharmaceuticals, and Novartis, as well as personal fees (honoraria) from Calithera Biosciences, BMS, Eisai Medical Research, Merck Sharp & Dohme (MSD), Deka Biosciences, Neoleukin Therapeutics, Exelixis, and Ono Pharmaceutical outside the submitted work. The remaining authors declare no competing interests.
